Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tonix Pharmaceuticals

13.63
+0.16001.19%
Post-market: 13.700.0700+0.51%19:59 EDT
Volume:777.82K
Turnover:10.27M
Market Cap:76.20M
PE:-1.76
High:13.67
Open:13.53
Low:12.35
Close:13.47
Loading ...

Tonix Pharmaceuticals Announces Research Agreement With Kenya Medical Research Institute (Kemri) to Design, Plan and Seek Regulatory Approval for a Phase I Clinical Study of Tnx-801 for Mpox in Kenya

THOMSON REUTERS
·
04 Nov 2024

Tonix Pharmaceuticals Announces Research Agreement with Kenya Medical Research Institute (KEMRI) to Design, Plan and Seek Regulatory Approval for a Phase I Clinical Study of TNX-801 for Mpox in Kenya

GlobeNewswire
·
04 Nov 2024

Tonix Pharmaceuticals Presented Data on Potential Mpox Vaccine Tnx-801 at World Vaccine Congress-Europe 2024

THOMSON REUTERS
·
01 Nov 2024

Tonix Pharmaceuticals Holding Corp - Tnx-801 Shows Tolerability and No Spreading in Immunocompromised Animals

THOMSON REUTERS
·
01 Nov 2024

Tonix Pharmaceuticals Presented Data on Potential Mpox Vaccine TNX-801 at World Vaccine Congress-Europe 2024

GlobeNewswire
·
01 Nov 2024

Tonix Pharmaceuticals to Present at BIO-Europe® 2024

GlobeNewswire
·
29 Oct 2024

Tonix Pharmaceuticals Announces Oral Presentation at the World Vaccine Congress Europe 2024

THOMSON REUTERS
·
24 Oct 2024

Tonix Pharmaceuticals Announces Oral Presentation at the World Vaccine Congress Europe 2024

GlobeNewswire
·
24 Oct 2024

Sector Update: Health Care Stocks Decline Thursday Afternoon

MT Newswires Live
·
18 Oct 2024

Tonix Pharmaceuticals Shares Surge After 1st Payment From Defense Department

MT Newswires Live
·
18 Oct 2024

Tonix Pharmaceuticals Receives First Contract Payment from U.S. Department of Defense for Accelerated Development of Broad-Spectrum Antivirals with the Defense Threat Reduction Agency (DTRA)

GlobeNewswire
·
17 Oct 2024

Empery Asset Management LP Acquires Shares in Tonix Pharmaceuticals

GuruFocus.com
·
17 Oct 2024

Tonix Pharmaceuticals Files New Drug Application With FDA for TNX-102 SL to Treat Fibromyalgia

MT Newswires Live
·
16 Oct 2024

BRIEF-Tonix Pharmaceuticals Announces Submission Of The TNX-102 Sl New Drug Application (NDA) For Fibromyalgia To The U.S. Food And Drug Administration (FDA)

Reuters
·
16 Oct 2024

Tonix Pharmaceuticals Holding Corp - FDA Decision on Tnx-102 Sl Expected in 2025

THOMSON REUTERS
·
16 Oct 2024

Tonix Pharmaceuticals Announces Submission of the Tnx-102 Sl New Drug Application (Nda) for Fibromyalgia to the U.S. Food and Drug Administration (FDA)

THOMSON REUTERS
·
16 Oct 2024